OTLK Overview
Upcoming Projects (OTLK)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (OTLK)
-
Investigating the potential of Outlook's LYTENAVA (ONS-5010) as a treatment for Wet AMD
Ticker: OTLK
Executed On: Jul 27, 2023 at 08:30 AM EDT -
A Second look: Discussing the commercial outlook of Coherus' Cimerli (ranibizumab biosimilar) and Outlook's Lytenava (ophthalmic formulation of bevacizumab) in Wet AMD
Tickers: CHRS, OTLK
Executed On: Mar 15, 2023 at 03:00 PM EDT -
Discussing the commercial outlook of Coherus' Cimerli (ranibizumab biosimilar) and Outlook's Lytenava (ophthalmic formulation of bevacizumab) in Wet AMD
Tickers: CHRS, OTLK
Executed On: Mar 14, 2023 at 03:00 PM EDT
Upcoming & Overdue Catalysts (OTLK)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (OTLK)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
